Preferred Label : sugemalimab;
Origin ID : C000723018;
UMLS CUI : C5418251;
ATC code(s)
- Currated CISMeF NLP mapping
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.ema.europa.eu/en/medicines/human/EPAR/cejemly
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
sugemalimab
sugemalimab
drug approval
europe
sugemalimab
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
adult
neoplasm metastasis
carcinoma, non-small-cell lung
antineoplastic combined chemotherapy protocols
infusions, intravenous
PD-L1 Inhibitors
PD-L1 Inhibitors
product surveillance, postmarketing
ALK Gene Alteration Negative
RET Gene Alteration Negative
ROS1 Gene Alteration Negative
Sensitizing EGFR Mutation Negative
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
---
